Effect of acute hyperglycemia and/or hyperinsulinemia on polymorphonuclear functions in healthy subjects

Metabolism: Clinical and Experimental

Volumn 55, Issue 6, 2006, Pages 811-818

  Fejfarová, Vladimíra ^a   Jirkovská, Alexandra ^a   Lupínková, Jana ^a   Kovář, Jan ^a   Kalanin, Ján ^a   Stříž, Ilja ^a   Skibová, Jelena ^a   Bouček, Petr ^a   Pelikánová, Terezie ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ADULT; ARTICLE; BODY MASS; DIABETES MELLITUS; FLOW CYTOMETRY; FLUORESCENCE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPERINSULINEMIA; IMMUNE FUNCTION TEST; INSULIN RELEASE; NORMAL HUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY BURST; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; NEUTROPHILS; PHAGOCYTOSIS; RESPIRATORY BURST;

EID: 33646525977     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.02.007     Document Type: Article

References (45)

1. Roitt I.M., Brostoff J., and Male D.K. Immunology. 4th ed. (1996), Gower Medical Publishing Ltd, London
2. Sawyer D.W., Donowitz G.R., and Mandell G.L. Polymorphonuclear neutrophils: an effective antimicrobial force. Rev Infect Dis 11 (1989) S1532-S1544
3. Furukawa S., Saito H., Matsuda T., et al. Relative effects of glucose and glutamin on reactive oxygen intermediate production by neutrophils. Shock 13 (2000) 274-278
4. Miller M.E. Phagocytic cell functions in diabetes mellitus. In: Gupta S. (Ed). Immunology of clinical and experimental diabetes (1984), Plenum, New York 369-383
5. Johnson R.B., and Newman S.L. Chronic granulomatous disease. Pediatr Clin North Am 24 (1977) 365-376
6. Reeves W.G., and Wilson R.M. Infection, immunity and diabetes. In: Alberti K.G.M.M., DeFronzo R.A., Keen H., and Zimmet P. (Eds). International textbook of diabetes mellitus (1992), Wiley, Chichester (UK) 1165-1171
7. Clark R.A., and Szot S. Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation. J Immunol 128 (1982) 1507-1513
8. Fialkow L., Chan C.K., Grinstein S., et al. Regulation of tyrosine phosphorylation in neutrophils by the NADPH oxidase. Role of reactive oxygen intermediates. J Biol Chem 268 (1993) 17131-17137
9. Murray H.W., Spitalny G.L., and Nathan C.F. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. J Immunol 134 (1985) 1619-1622
10. Donadebian H.D. Congenital and acquired neutrophil abnormalities. In: Klempner M.S. (Ed). Phagocytes and disease (1989), Kluwer, Dordrecht 103-118
11. Robinson J.P., and Carter W.O. Flow cytometric analysis of granulocytes. In: Bauer K.D. (Ed). Clinical flow cytometry, principles and applications (1993), Williams and Wilkins, Baltimore 405-433
12. Mowat A.G., and Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 284 (1971) 621-627
13. Bagdade J.D., Stewart M., and Walters E. Impaired granulocyte adherence. A reversible defect in patients with poorly controlled diabetes mellitus. Diabetes 27 (1978) 677-681
14. Shah S.V., Wallin J.D., and Eilen S.D. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metab 57 (1983) 402-409
15. Delamaire M., Maugendre D., Moreno M., et al. Impaired leukocyte functions in diabetic patients. Diabet Med 14 (1997) 29-34
16. Vučič M., Gavella M., Božikov V., et al. Superoxidedismutase activity in lymphocytes and polymorphonuclear cells of diabetic patients. Eur J Clin Chem Clin Biochem 35 (1997) 517-521
17. Wilson R.M., Tomplinson D.R., and Reeves W.G. Neutrophil sorbitol production impairs oxidative killing in diabetes. Diabet Med 4 (1987) 37-40
18. Walrand S., Guillet C., Boirie Y., et al. In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions. J Leukoc Biol 76 (2004) 1104-1110
19. Esmann V., Solling H., and Juhl H. Allosteric and covalent control of glycogen synthase from leukocytes. Int J Biochem 13 (1981) 1123-1126
20. Sentochnik D.E., and Eliopoulos G.M. Infection and diabetes. In: Zahn C.R., and Weir G.C. (Eds). Joslin's diabetes. 13th ed (1994), Lea and Febiger, Philadelphia 867-888
21. Pozzilli P., and Leslie R.D.G. Infections and diabetes: mechanisms and prospects for prevention. Diabet Med 11 (1994) 935-941
22. Bessman A.N., and Sapico F.L. Infections in diabetic patients: the role of immune dysfunction and pathogen virulence factors. J Diabetes Complications 6 (1992) 258-262
23. Marhoffer W., Stein M., Maeser E., et al. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 15 (1992) 256-259
24. 2 species in leukocytes from poorly controlled diabetic patients. Diabetes Care 15 (1992) 1050-1052
25. Boland O.M., Blackwell C.C., Clarke B.F., and Ewing D.J. Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus. Diabetes 42 (1993) 336-340
26. Llorente L., De La Fuente H., Richaud-Patin Y., et al. Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology. Immunol Lett 74 (2000) 239-244
27. Cendoroglo M., Sundaram S., Jaber B.L., et al. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. Am J Kidney Dis 31 (1998) 273-282
28. Lin X., Candlish J.K., and Thai A.C. Superoxide production by neutrophils from diabetics and normal subjects in response to glucose and galactose. Exp Mol Pathol 58 (1993) 229-236
29. Tebbs S.E., Lumbwe C.M., Tesfaye S., et al. The influence of aldose reductase on the oxidative burst in diabetic neutrophils. Diabetes Res Clin Prac 15 (1992) 121-130
30. Thomson G.A., Fisher B.M., Gemmel C.G., et al. Attenuated neutrophils respiratory burst following acute hypoglycemia in diabetic patients and normal subjects. Acta Diabetol 34 (1997) 253-256
31. World Health Organization Expert Committee. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation: Part 1. Diagnosis and classification of diabetes mellitus (1999), WHO, Geneva (Switzerland)
32. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) 214-223
33. Pelikánová T., Kazdová L., Chvojková S., et al. Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients. Metabolism 50 (2001) 1472-1478
34. Beatty O.L., Harper R., Sheridan B., et al. Insulin resistance in offspring of hypertensive parents. BMJ 307 (1993) 92-96
35. Grzybowski J., Janiak M.K., Oidak E., et al. New cytokine dressings: II. Stimulation of oxidative burst in leukocytes in vitro and reduction of viable bacteria within an infected wound. Int J Pharm 184 (1999) 179-187
36. Shalekoff S., Tiemessen C.T., Gray C.M., et al. Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 5 (1998) 41-44
37. Rosse W., and Bunn H.F. Hemolytic anemias and acute blood loss. In: Fauci A.S. (Ed). Harrison's principles of internal medicine (1998), McGraw-Hill, USA 659-672
38. Liberek T., Topley N., Jorres A., et al. Peritoneal dialysis fluid inhibition of phagocyte function: effect of osmolarity and glucose concentration. J Am Soc Nephrol 3 (1993) 1508-1515
39. Nielson C.P., and Hindson D.A. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 38 (1989) 1031-1035
40. Safronova V.G., Gabdoulkhakova A.G., Miller A.V., et al. Variations of the effect of insulin on neutrophil respiratory burst. The role of tyrosine kinases and phosphatases. Biochemistry 66 (2001) 840-849
41. Cavalot F., Anfossi G., Russo I., et al. Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties. Horm Metab Res 24 (1992) 225-228
42. Esmann V. The polymorphonuclear leukocyte in diabetes mellitus. J Clin Chem Clin Biochem 21 (1983) 561-567
43. Spagnoli A., Spadoni G.L., Sesti G., et al. Effect of insulin on hydrogen peroxide production by human polymorphonuclear leukocytes. Studies with monoclonal anti-insulin receptor antibodies, and an agonist and an inhibitor of protein kinase C. Horm Res 43 (1995) 286-293
44. Hu H., Hjemdahl P., and Li N. Effects of insulin on platelet and leukocyte activity in whole blood. Thromb Res 107 (2002) 209-215
45. Stites D.P., and Terr A.I. Basic and clinical immunology. 8th ed. (1994), Appleton and Lange, Stamford